Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death

In this study, we demonstrate that angiotensin II (Ang II) protects dopamine (DA) neurons from rotenone toxicity in vitro. Primary ventral mesencephalic (VM) cultures from E15 rats were grown for 5 days and then cultured in the presence of the mitochondrial complex I inhibitor, rotenone. Acute exposure (20 h) to 20 nM rotenone reduced the number of tyrosine hydroxylase-positive (TH+) neurons by 50 +/- 6% when compared to untreated cultures. Pre-treatment of VM cultures with 100 nM Ang II decreased TH+ neuronal loss to 25 +/- 10% at the 20-nM rotenone concentration. Ang II in the presence of the angiotensin type 1 receptor (AT1R) antagonist, losartan, was even more effective in protecting DA neurons showing a loss of only 13 +/- 4% at 20 nM rotenone. Conversely, the AT2R antagonist, PD123319, abolished the protective effects of Ang II. Furthermore, both the NMDA receptor antagonist, MK801, and the antioxidant, alpha-tocopheryl succinate (vitamin E analogue), prevented rotenone-induced toxicity. Here, we show that acute exposure of VM cultures to the pesticide rotenone leads to dopaminergic neuronal cell death and that angiotensin acting through the AT2 receptor protects dopamine neurons from rotenone toxicity.

[1]  M. Horne,et al.  The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease. , 2000, Australian and New Zealand journal of medicine.

[2]  W. Nicklas,et al.  Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.

[3]  W. Schmidt,et al.  Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats , 2002, Behavioural Brain Research.

[4]  M. Horiuchi,et al.  Angiotensin II type 2 receptor mediates programmed cell death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Kato,et al.  Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice , 2004, Neurological research.

[6]  K. Jacobson,et al.  Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors , 2001, Journal of hypertension.

[7]  S. Moore,et al.  Effects of mutations in the highly conserved DRY motif on binding affinity, expression, and G-protein recruitment of the human angiotensin II type-2 receptor. , 2002, Brain research. Molecular brain research.

[8]  Mingyan Zhu,et al.  Angiotensin II Type 2 Receptor Stimulation of Neuronal Delayed-Rectifier Potassium Current Involves Phospholipase A2 and Arachidonic Acid , 1998, The Journal of Neuroscience.

[9]  R. Camicioli,et al.  Parkinsonism and occupational exposure to pesticides , 2001, Occupational and environmental medicine.

[10]  I. Armando,et al.  Angiotensin II AT1 and AT2 Receptor Types Regulate Basal and Stress‐Induced Adrenomedullary Catecholamine Production through Transcriptional Regulation of Tyrosine Hydroxylase , 2004, Annals of the New York Academy of Sciences.

[11]  Todd B. Sherer,et al.  An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage , 2002, The Journal of Neuroscience.

[12]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[13]  J. Langston,et al.  Increased striatal dopamine turnover following acute administration of rotenone to mice , 2000, Brain Research.

[14]  P. Wong,et al.  Expression of angiotensin II AT2 receptor in the acute phase of stroke in rats , 2000, Neuroreport.

[15]  S. Omaye,et al.  Antioxidant and prooxidant roles for β-carotene, α-tocopherol and ascorbic acid in human lung cells , 2001 .

[16]  Mingyan Zhu,et al.  Angiotensin II increases neuronal delayed rectifier K(+) current: role of 12-lipoxygenase metabolites of arachidonic acid. , 2000, Journal of neurophysiology.

[17]  C. Hock,et al.  Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer’s dementia , 2001, Neurobiology of Aging.

[18]  W. Schelman,et al.  Inhibitory effects of angiotensin on NMDA-induced cytotoxicity in primary neuronal cultures , 2004, Brain Research Bulletin.

[19]  D. Howells,et al.  Effect of Chronic Angiotensin‐Converting Enzyme Inhibition on Striatal Dopamine Content in the MPTP‐Treated Mouse , 1999, Journal of neurochemistry.

[20]  M. Cooper,et al.  Apoptosis and Angiotensin II: Yet Another Renal Regulatory System? , 2001, Nephron Experimental Nephrology.

[21]  Shinn-Zong Lin,et al.  Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson's disease , 2002, Journal of the Neurological Sciences.

[22]  T. Unger.  Inhibiting Renin-Angiotensin in the Brain: the Possible Therapeutic Implications , 2001, Blood pressure. Supplement.

[23]  Y. Itoyama,et al.  Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice , 2005, European Neuropsychopharmacology.

[24]  S. Moore,et al.  Angiotensin II attenuates chemical hypoxia-induced caspase-3 activation in primary cortical neuronal cultures , 2004, Brain Research Bulletin.

[25]  A. Black,et al.  Angiotensin–converting enzyme (ACE) inhibitors and angio–oedema , 1997, The British journal of dermatology.

[26]  O. Hornykiewicz.  Brain monoamines and parkinsonism. , 1975, National Institute on Drug Abuse research monograph series.

[27]  S. Dunnett,et al.  Neural transplantation methods , 2000 .

[28]  K. Heidenreich,et al.  The pesticide rotenone induces caspase‐3‐mediated apoptosis in ventral mesencephalic dopaminergic neurons , 2003, Journal of neurochemistry.

[29]  C. Sumners,et al.  Angiotensin II Type 2 Receptor-Mediated Apoptosis of Cultured Neurons from Newborn Rat Brain* * This work was supported by a grant from the NIH (NS-19441) and a postdoctoral fellowship (to U.V.S.) from the American Heart Association, Florida Affiliate. , 1999, Endocrinology.

[30]  N. Barnes,et al.  Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders. , 1996, European journal of pharmacology.

[31]  Todd B. Sherer,et al.  Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.

[32]  C. Johnston,et al.  Angiotensin receptors: distribution, signalling and function. , 2001, Clinical science.

[33]  Langston Jw,et al.  Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1983 .

[34]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[36]  J. Parga,et al.  Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors , 2004, The European journal of neuroscience.

[37]  U. Ungerstedt,et al.  Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[38]  J. Schulz,et al.  Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra , 1997, Brain Research.

[39]  M. Niwa,et al.  The increase in angiotensin type-2 receptor mRNA level by glutamate stimulation in cultured rat cortical cells , 1998, Brain Research.

[40]  F. Forastiere,et al.  Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users , 2002, Neurological Sciences.

[41]  S. Moore,et al.  Angiotensin type 2 receptor neuroprotection against chemical hypoxia is dependent on the delayed rectifier K+ channel, Na+/Ca2+ exchanger and Na+/K+ ATPase in primary cortical cultures , 2004, Neuroscience Research.

[42]  Marc W Fariss,et al.  Vitamin E therapy in Parkinson's disease. , 2003, Toxicology.

[43]  T. Grammatopoulos,et al.  Angiotensin protects cortical neurons from hypoxic-induced apoptosis via the angiotensin type 2 receptor. , 2002, Brain research. Molecular brain research.

[44]  Y. Ohgami,et al.  Transient upregulation of the AT2 receptor mRNA level after global ischemia in the rat brain , 1996, Neuropeptides.

[45]  V. Uversky,et al.  Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's disease , 2001, FEBS letters.

[46]  K. Heidenreich,et al.  Growth Factors Rescue Embryonic Dopamine Neurons from Programmed Cell Death , 1996, Experimental Neurology.

[47]  R. Bache,et al.  Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/PKB. , 2003, American journal of physiology. Heart and circulatory physiology.

[48]  C. C. Johnson,et al.  The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living , 1998, Neurology.